In Yemen's war, untreated cancer patients wait for death TAIZ, Yemen (AP) -- When Ali Ghanem's doctors told him his cancer had spread from his colon to his backbone, they said they didn't have the facilities to give him the needed radiation treatment in his home city of Taiz, in central Yemen, and that he needed to get to the capital.
3-year-old battling stage 4 brain cancer to be named honorary FDNY firefighter A Hawaii boy battling deadly brain cancer recently received news that he’d receive an honor he’s dreamt of during his short three years of life.
Lung cancer breathalyzer in UK clinical trials A breathalyzer designed to detect the early signs of lung cancer is undergoing clinical trials at 17 British hospitals, with the aim of having the non-invasive technology in clinics in 2017.
Pfizer's Ibrance delays breast cancer progression: study Pfizer Inc's Ibrance in combination with another commonly-used drug kept advanced breast cancer in check significantly longer than the standard treatment alone in a late stage study, according to data released on Wednesday.
How sex hormones might treat certain diseases Androgens, a kind of sex hormone, have been used to treat certain genetic blood disorders for decades.
FDA OKs immunotherapy drugs for bladder, blood cancers TRENTON, N.J. (AP) -- U.S. regulators have approved the first drug for bladder cancer that harnesses the body's immune system, the first major advance in three decades against the most common type of bladder cancer.
Precision medicine approach to cancer improves on older methods: study Precision medicine, or the practice of targeting biological markers on a patient's tumors, proved significantly more effective at shrinking tumors and stalling the progression of cancer in the first large-scale analysis of such treatments.
Studies suggest drugs for advanced lung, skin cancers extend patients' lives Two new drugs that help the immune system fight some of the deadliest cancers are helping patients live years longer than older treatments, according to clinical trial results that should further boost confidence in this approach to oncology.
Gerri Willis: I have breast cancer I’m not the kind of person who enjoys talking about my medical conditions but I am talking about this – and here is why.
